APX-1004F

N/A

Report date: 2024/08/01 17:45:58
NME

Base Information

Drug NameAPX-1004F
Drug Alias NameAPX-1004-FAPX-1004F
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNADPH oxidase inhibitors
TargetsNADPH oxidase
Therapy Area/IndicationsWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSamjin Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAptabio Therapeutics IncSamjin Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsWet age-related macular degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A